FindTrial
Sign In

Effect of Vagus Nerve Stimulation in women with Fibromyalgia

Effect of Transcutaneous Auricular Vagus Nerve Stimulation in women with Fibromyalgia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3xqd5yz
Enrollment
Unknown
Registered
2024-11-08
Start date
2024-10-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia

Interventions

This is a randomized, crossover, sham-controlled clinical trial that will be conducted with 14 women diagnosed with fibromyalgia, following the American College of Rheumatology (ACR) criteria. The stu
consequently, the participant will not rec
E02.331.800

Sponsors

Universidade Federal de Santa Catarina - UFSC
Lead Sponsor
Universidade Federal de Santa Catarina - UFSC
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Female individuals; age between 18 and 65 years old; patients with fibromyalgia; walk independently; understand brazilian portuguese

Exclusion criteria

Exclusion criteria: IIndividuals with red flags like fracture or cancer; suspected or confirmed pregnancy; unstable heart conditions; absence of ear

Design outcomes

Primary

MeasureTime frame
It is expected to find a reduction in the intensity and distribution of perceived pain, by at least two points in the intervention group—

Secondary

MeasureTime frame
Assess cognitive function at the beginning and end of the study;Assess heart rate variability at the beginning and end of the study;Assess the serum concentration of Brain-Derived Neurotrophic Factor (BDNF) at the beginning and end of the study—

Countries

Brazil

Contacts

Public ContactMarcos Neves

Universidade Federal de Santa Catarina

marcoslisboaneves@gmail.com+55(48)98818-9596

Outcome results

None listed

Source: REBEC (via WHO ICTRP)